SLBT
SL Science Holding Limited Ordinary Shares
NASDAQ · Healthcare · Biotechnology · US
$1.53
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 375.66x
- Price / sales
- 390.47x
- Price / cash flow
- -449.24x
Enterprise value
- Enterprise value
- $856.9M
- EV / sales
- 390.00x
- EV / EBITDA
- -228.89x
- EV / EBIT
- -223.30x
- Market cap
- $858.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025